Cerys Propert-Lewis Selected Research

Drug Therapy (Chemotherapy)

1/2015

A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cerys Propert-Lewis Research Topics

Disease

1	Leiomyosarcoma 01/2015

Drug/Important Bio-Agent (IBA)

1	Docetaxel (Taxotere)FDA Link 01/2015
1	Gemcitabine FDA Link 01/2015

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2015
1	Therapeutics 01/2015